To be successful in life science investing, it is important to be constantly aware of changes in the regulatory and reimbursement environment. Recently, these factors have been further compounded by the structural changes in healthcare delivery created by hospital consolidations, mergers between insurers and providers, and "costs over outcomes" as key decisions for mass adoption. These drivers impact investment decisions for angel investors, and ultimately the strategy to achieve successful exit multiples. Join us to make sure you are up to date on the most recent trends and how they might affect your portfolio companies and life science investment strategies.

Speaker:  Allan May, Life Science Angels

Presentation Materials

Access the Recording